AC Immune (ACIU) Shares Outstanding (2017 - 2025)

AC Immune (ACIU) has 9 years of Shares Outstanding data on file, last reported at $127.3 million in Q4 2025.

• Quarterly Shares Outstanding rose 11.06% year-over-year to $127.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $127.3 million (up 11.06% YoY) and the FY2025 annual result came in at $122.7 million, up 7.06% from the prior year.
• Shares Outstanding improved to $127.3 million in Q4 2025 per ACIU's latest filing, from $114.6 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $127.3 million in Q4 2025 and bottomed at $86.8 million in Q4 2022.
• The 5-year median for Shares Outstanding is $111.8 million (2023), against an average of $106.2 million.
• The widest annual swing landed in 2022, when Shares Outstanding declined 4.12%; it then advanced 28.84% in 2023.
• Tracing ACIU's Shares Outstanding over 5 years: stood at $90.5 million in 2021, then slipped by 4.12% to $86.8 million in 2022, then increased by 28.84% to $111.8 million in 2023, then rose by 2.49% to $114.6 million in 2024, then climbed by 11.06% to $127.3 million in 2025.
• Per Business Quant, the three latest ACIU Shares Outstanding figures stand at $127.3 million (Q4 2025), $114.6 million (Q4 2024), and $111.8 million (Q4 2023).

Peer Comparison